Form 4 holding
Director
NEKTAR THERAPEUTICS
- Security class
- Common Stock
- Shares / value
- 16,417
- Estimated value
- $1,146,070
- Report date
- 23 Sep 2026
- Price
- $69.81
- Ownership
- Direct
Roy A. Whitfield - Director at NEKTAR THERAPEUTICS
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- NKTR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Roy A. Whitfield since 04 Oct 2025
Reported holdings for Roy A. Whitfield in NEKTAR THERAPEUTICS
Form 4 holding
Director
NEKTAR THERAPEUTICS
- Security class
- Common Stock
- Shares / value
- 3,434
- Estimated value
- $239,727
- Report date
- 23 Sep 2026
- Price
- $69.81
- Ownership
- by Whitfield Family 2020 Trust
Form 4 holding
Director
NEKTAR THERAPEUTICS
- Security class
- Common Stock
- Shares / value
- 1,334
- Estimated value
- $93,126
- Report date
- 23 Sep 2026
- Price
- $69.81
- Ownership
- by Family Trust
Form 4 holding
Director
NEKTAR THERAPEUTICS
- Security class
- Stock Option
- Shares / value
- 4,000
- Estimated value
- Report date
- 23 Sep 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Roy A. Whitfield in NEKTAR THERAPEUTICS
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.